1.
Pua MJ, Santiago RM, Andal JJ, Ang D. Programmed Death Ligand 1 (PD-L1) Expression and its Association with Driver Mutations among Patients with Non-Small Cell Lung Cancer in a Private Tertiary Care Setting. Phil Journal Path [Internet]. 2022 Dec. 28 [cited 2024 Mar. 28];7(2):36-45. Available from: https://philippinejournalofpathology.org/index.php/PJP/article/view/365